Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carroll

Showing results (371-380 of 26,011) with videos related to

Pageof 2,602
Sort By:
Biotechnology Healthcare|April 6, 2012
Biogenetic tests emerge from their chrysalisJohn Carroll
Biotechnology Healthcare|April 6, 2012
Convergence in the midst of competitionJohn Carroll
Biotechnology Healthcare|April 6, 2012
Flexibility in biologic benefit designs can deliver big rewardsJohn Carroll
Biotechnology Healthcare|April 6, 2012
Why Bigger Is Better For Controlling Oncology Spend: It offers less competition - perhaps - but can be a boon for evidence-based pathway initiativesJohn Carroll
Biotechnology Healthcare|April 6, 2012
The 3.3 percent rx dilemmaJohn Carroll
Managed Care (Langhorne, Pa.)|October 7, 2014
Sovaldi dilemma likely to get worseJohn Carroll
Nursing Science Quarterly|June 13, 2023
Insights and Power of StorytellingKaren Carroll
Managed Care (Langhorne, Pa.)|May 2, 2008
Aetna and Hannaford make a Singapore connectionJohn Carroll
Genome Medicine|November 17, 2016
Genome editing: progress and challenges for medical applicationsDana Carroll
Journal of the American College of Surgeons|February 27, 2017
Iatrogenic Bile Duct InjuriesBrendan Carroll
Pageof 2,602

Showing results (371-380 of 26,011) with videos related to

Sort By:
Pageof 2,602
Biotechnology Healthcare|April 6, 2012
Biogenetic tests emerge from their chrysalisJohn Carroll
Biotechnology Healthcare|April 6, 2012
Convergence in the midst of competitionJohn Carroll
Biotechnology Healthcare|April 6, 2012
Flexibility in biologic benefit designs can deliver big rewardsJohn Carroll
Biotechnology Healthcare|April 6, 2012
Why Bigger Is Better For Controlling Oncology Spend: It offers less competition - perhaps - but can be a boon for evidence-based pathway initiativesJohn Carroll
Biotechnology Healthcare|April 6, 2012
The 3.3 percent rx dilemmaJohn Carroll
Managed Care (Langhorne, Pa.)|October 7, 2014
Sovaldi dilemma likely to get worseJohn Carroll
Nursing Science Quarterly|June 13, 2023
Insights and Power of StorytellingKaren Carroll
Managed Care (Langhorne, Pa.)|May 2, 2008
Aetna and Hannaford make a Singapore connectionJohn Carroll
Genome Medicine|November 17, 2016
Genome editing: progress and challenges for medical applicationsDana Carroll
Journal of the American College of Surgeons|February 27, 2017
Iatrogenic Bile Duct InjuriesBrendan Carroll
Pageof 2,602